Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 – U.S. Food & Drug Administration Commentary: FDA Rejects Ivermectin, Despite Growing Interest In Some Corners Of The Internet – Brief19 Related: RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19
The post FDA: Why you should not use Ivermectin to treat or prevent COVID-19 appeared first on Links Medicus.
COVID antibody treatments show promise for preventing severe disease – Nature
The post COVID antibody treatments show promise for preventing severe disease appeared first on Links Medicus.
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant – New England Journal of Medicine Commentaries: AstraZeneca vaccine doesn’t prevent B1351 COVID in early trial – CIDRAP AND Oxford/AstraZeneca Fails to Prevent Mild to Moderate Covid-19 From B.1.351 (“South Africa”) Variant – Brief19
The post RCT: Oxford/AstraZeneca vaccine does not protect against mild-to-moderate Covid-19 due to the B.1.351 variant appeared first on Links Medicus.
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients – JAMA
The post Immunogenicity of a single dose of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients appeared first on Links Medicus.
The Oxygen Cascade During Exercise in Health and Disease – Mayo Clinic Proceedings
The post The oxygen cascade during exercise in health and disease appeared first on Links Medicus.
What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1) – Annals of Internal Medicine
The post ACP Practice Points: What is the antibody response and role in conferring natural immunity after SARS-CoV-2 infection? appeared first on Links Medicus.
More Than Half of COVID-19 Patients Report Depressive Symptoms Months Later, Study Finds – Psychiatric News Alert Original study: Association of Acute Symptoms of COVID-19 and Symptoms of Depression in Adults – JAMA Network Open Commentary on Twitter Survey study finds 52% of individuals with prior #COVID19 met criteria for moderate or greater symptoms […]
The post More than half of COVID-19 patients report depressive symptoms months later, study finds appeared first on Links Medicus.
B.1.1.7 variant linked to 55% higher mortality compared to other strains of SARS-CoV-2 – London School of Hygiene & Tropical Medicine Original study: Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 – Nature Related: Death rate 64% higher with B117 COVID variant, study finds (study and commentary) Commentary on Twitter (thread – Click […]
The post B.1.1.7 variant linked to 55% higher mortality compared to other strains of SARS-CoV-2 appeared first on Links Medicus.
Antibody Response After SARS-CoV-2 Infection and Implications for Immunity: A Rapid Living Review – Annals of Internal Medicine
The post Antibody response after SARS-CoV-2 infection and implications for immunity: A rapid living review appeared first on Links Medicus.
Update on the safety of COVID-19 Vaccine AstraZeneca Related: Countries should continue AstraZeneca rollout: WHO – MedicalXpress AND Expert reaction to news that Germany has halted vaccinations with the Oxford-AstraZeneca COVID-19 vaccine – Science Media Centre AND AstraZeneca finds no evidence of increased blood clot risk from vaccine – Reuters AND Data suggest no increased […]
The post Update on the safety of COVID-19 Vaccine AstraZeneca appeared first on Links Medicus.